Lu Hongbo Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

ARWR Quotes by TradingView

Lu Hongbo is Director of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 54,982 shares of ARWR, which is worth approximately $2.27 Million. The most recent transaction as insider was on Dec 16, 2025, when has been sold 7,819 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55K
16.58% 3M change
16.58% 12M change
Total Value Held $2.27 Million

Lu Hongbo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 16 2025
BUY
Grant, award, or other acquisition
-
7,819 Added 12.45%
54,982 Common Stock
Dec 18 2024
BUY
Grant, award, or other acquisition
$384,691 $22.99 p/Share
16,733 Added 26.19%
47,163 Common Stock
Mar 20 2024
BUY
Open market or private purchase
$27,500 $27.5 p/Share
1,000 Added 2.88%
33,680 Common Stock
Mar 19 2024
BUY
Open market or private purchase
$28,000 $28.0 p/Share
1,000 Added 2.97%
32,680 Common Stock
Mar 18 2024
BUY
Open market or private purchase
$27,490 $27.49 p/Share
1,000 Added 3.06%
31,680 Common Stock

Also insider at

TPTX
Turning Point Therapeutics, Inc.
Director
TERN
Terns Pharmaceuticals, Inc. Healthcare
ZBIO
Zenas BioPharma, Inc.
Director
Lu Hongbo

Lu Hongbo

Director
San Diego, CA

Track Institutional and Insider Activities on ARWR

Follow ARROWHEAD PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARWR shares.

Notify only if

Insider Trading

Get notified when an Arrowhead Pharmaceuticals, Inc. insider buys or sells ARWR shares.

Notify only if

News

Receive news related to ARROWHEAD PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARWR